Descripción de la oferta
Fundación Pública Andaluza Progreso y Salud in Spain invites applications for a First Stage Researcher (R1) to participate in the project Combined strategy to improve anti-CLL1 CAR-T cell therapy for AML using LNPs and genome editing. Joined APPLIED GENOME EDITING FOR ADVANCED THERAPIES group led by Dr.Karim Benabdellah. Candidates must hold a Bachelor's degree in Biotechnology/Biomedicine/Biology/Biochemistry, have >1 year biomedical research experience, and meet CEFR B1 English.
#J-18808-Ljbffr
